| Dr William Charles Burgette, DO | |
|
6810 Perimeter Dr Ste 200, Dublin, OH 43016-8013 | |
| (614) 827-8700 | |
| (614) 827-8701 |
| Full Name | Dr William Charles Burgette |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 15 Years |
| Location | 6810 Perimeter Dr Ste 200, Dublin, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326289257 | NPI | - | NPPES |
| H375521 | Other | OH | MEDICARE (OHIOHEALTH) |
| 000001133176 | Other | OH | ANTHEM |
| 0136604 | Medicaid | OH |
| Facility Name | Location | Facility Type |
|---|---|---|
| Summit Orthopaedic Home Care | Columbus, OH | Home health agency |
| Dublin Methodist Hospital | Dublin, OH | Hospital |
| Mary Rutan Hospital | Bellefontaine, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Orthopedic One, Inc. | 3072598283 | 253 |
| Ohiohealth Corporation | 6305758426 | 1900 |
News Archive
Raptor Pharmaceuticals Corp. has announced positive results in its Phase IIa study of oral 4-methylpyrazole ("4-MP") in subjects with ALDH2 deficiency, or ethanol intolerance, as the initial development stage of its Convivia program.
Researchers may be able to tinker with a single amino acid of an enzyme that helps viruses multiply to render them harmless, according to molecular biologists who say the discovery could pave the way for a fast and cheap method of making vaccines.
Feed the Future Deputy Coordinator for Development Julie Howard writes on State's "DipNote" blog about attending the 10th annual African Growth and Opportunity Act (AGOA) forum in Zambia and an announcement from U.S. Trade Representative Ron Kirk that the U.S. will provide "up to $30 million per year for four years to support trade expansion in Africa".
The so-called RANK protein and the molecule that binds to it, the RANK ligand or RANKL, form a focus of the work of Josef Penninger, director of the Institute of Molecular Biotechnology (IMBA) in Vienna. In 1999 his group deleted the RANKL gene from mice and showed that the RANK/RANKL system was the "master regulator" governing bone loss (Kong et al. 1999 Nature 402, 304-309).
As part of their efforts to improve the effectiveness of both security and clinical workflows in the healthcare delivery process, Sentillion, whose identity and access management (IAM) solutions are the most widely implemented in healthcare, today announced their participation in the "Steering Committee on Telehealth and Healthcare Informatics" Healthcare Information Technology Showcase on Thursday, September 24th on Capitol Hill. The Technology Showcase is part of the activities of "National Health IT Week" going on September 21st – 25th in Washington DC.
› Verified 2 days ago
| Entity Name | Ohiohealth Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578545273 PECOS PAC ID: 6305758426 Enrollment ID: O20031105000532 |
News Archive
Raptor Pharmaceuticals Corp. has announced positive results in its Phase IIa study of oral 4-methylpyrazole ("4-MP") in subjects with ALDH2 deficiency, or ethanol intolerance, as the initial development stage of its Convivia program.
Researchers may be able to tinker with a single amino acid of an enzyme that helps viruses multiply to render them harmless, according to molecular biologists who say the discovery could pave the way for a fast and cheap method of making vaccines.
Feed the Future Deputy Coordinator for Development Julie Howard writes on State's "DipNote" blog about attending the 10th annual African Growth and Opportunity Act (AGOA) forum in Zambia and an announcement from U.S. Trade Representative Ron Kirk that the U.S. will provide "up to $30 million per year for four years to support trade expansion in Africa".
The so-called RANK protein and the molecule that binds to it, the RANK ligand or RANKL, form a focus of the work of Josef Penninger, director of the Institute of Molecular Biotechnology (IMBA) in Vienna. In 1999 his group deleted the RANKL gene from mice and showed that the RANK/RANKL system was the "master regulator" governing bone loss (Kong et al. 1999 Nature 402, 304-309).
As part of their efforts to improve the effectiveness of both security and clinical workflows in the healthcare delivery process, Sentillion, whose identity and access management (IAM) solutions are the most widely implemented in healthcare, today announced their participation in the "Steering Committee on Telehealth and Healthcare Informatics" Healthcare Information Technology Showcase on Thursday, September 24th on Capitol Hill. The Technology Showcase is part of the activities of "National Health IT Week" going on September 21st – 25th in Washington DC.
› Verified 2 days ago
| Entity Name | Orthopedic One, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548289697 PECOS PAC ID: 3072598283 Enrollment ID: O20040622000841 |
News Archive
Raptor Pharmaceuticals Corp. has announced positive results in its Phase IIa study of oral 4-methylpyrazole ("4-MP") in subjects with ALDH2 deficiency, or ethanol intolerance, as the initial development stage of its Convivia program.
Researchers may be able to tinker with a single amino acid of an enzyme that helps viruses multiply to render them harmless, according to molecular biologists who say the discovery could pave the way for a fast and cheap method of making vaccines.
Feed the Future Deputy Coordinator for Development Julie Howard writes on State's "DipNote" blog about attending the 10th annual African Growth and Opportunity Act (AGOA) forum in Zambia and an announcement from U.S. Trade Representative Ron Kirk that the U.S. will provide "up to $30 million per year for four years to support trade expansion in Africa".
The so-called RANK protein and the molecule that binds to it, the RANK ligand or RANKL, form a focus of the work of Josef Penninger, director of the Institute of Molecular Biotechnology (IMBA) in Vienna. In 1999 his group deleted the RANKL gene from mice and showed that the RANK/RANKL system was the "master regulator" governing bone loss (Kong et al. 1999 Nature 402, 304-309).
As part of their efforts to improve the effectiveness of both security and clinical workflows in the healthcare delivery process, Sentillion, whose identity and access management (IAM) solutions are the most widely implemented in healthcare, today announced their participation in the "Steering Committee on Telehealth and Healthcare Informatics" Healthcare Information Technology Showcase on Thursday, September 24th on Capitol Hill. The Technology Showcase is part of the activities of "National Health IT Week" going on September 21st – 25th in Washington DC.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr William Charles Burgette, DO 6810 Perimeter Dr Ste 200, Dublin, OH 43016-8013 Ph: (614) 827-8700 | Dr William Charles Burgette, DO 6810 Perimeter Dr Ste 200, Dublin, OH 43016-8013 Ph: (614) 827-8700 |
News Archive
Raptor Pharmaceuticals Corp. has announced positive results in its Phase IIa study of oral 4-methylpyrazole ("4-MP") in subjects with ALDH2 deficiency, or ethanol intolerance, as the initial development stage of its Convivia program.
Researchers may be able to tinker with a single amino acid of an enzyme that helps viruses multiply to render them harmless, according to molecular biologists who say the discovery could pave the way for a fast and cheap method of making vaccines.
Feed the Future Deputy Coordinator for Development Julie Howard writes on State's "DipNote" blog about attending the 10th annual African Growth and Opportunity Act (AGOA) forum in Zambia and an announcement from U.S. Trade Representative Ron Kirk that the U.S. will provide "up to $30 million per year for four years to support trade expansion in Africa".
The so-called RANK protein and the molecule that binds to it, the RANK ligand or RANKL, form a focus of the work of Josef Penninger, director of the Institute of Molecular Biotechnology (IMBA) in Vienna. In 1999 his group deleted the RANKL gene from mice and showed that the RANK/RANKL system was the "master regulator" governing bone loss (Kong et al. 1999 Nature 402, 304-309).
As part of their efforts to improve the effectiveness of both security and clinical workflows in the healthcare delivery process, Sentillion, whose identity and access management (IAM) solutions are the most widely implemented in healthcare, today announced their participation in the "Steering Committee on Telehealth and Healthcare Informatics" Healthcare Information Technology Showcase on Thursday, September 24th on Capitol Hill. The Technology Showcase is part of the activities of "National Health IT Week" going on September 21st – 25th in Washington DC.
› Verified 2 days ago
David K Kim, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6785 Bobcat Way Ste 300, Dublin, OH 43016 Phone: 614-890-6555 Fax: 614-823-8881 | |
L Candace Jennings, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 4019 W Dublin Granville Rd, Dublin, OH 43017 Phone: 614-293-2957 Fax: 614-688-3700 | |
Dr. Victor Paul Strimbu, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6840 Perimeter Dr, Dublin, OH 43016 Phone: 614-827-8700 Fax: 614-827-8701 | |
Dr. Bryce Fincham, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 5400 Frantz Rd, Ste. 250, Dublin, OH 43016 Phone: 614-544-6366 Fax: 614-544-6350 | |
Robert Andrew Magnussen, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3900 Stoneridge Ln Ste C, Dublin, OH 43017 Phone: 614-366-9324 Fax: 614-366-9339 | |
Ryan Chessman Jefferson, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 6810 Perimeter Dr Ste 200, Dublin, OH 43016 Phone: 614-827-8700 |